Patel et al. illustrated that overexpression of miR-16 and miR-15a inhibits BMI1 levels and enhances ROS production in breast cancer cells, which causes a significant impairment in the mitochondrial membrane potential. The gene discussed is BMI1; the disease is breast carcinoma.